Pharma Journalist 9027 posts 0 comments

SMi Reports: The Injectable Drug Delivery Conference returns as a virtual event on 12th and 13th May 2021 Part of Europe’s leading Injectable conference series, we will assess…
Read More...

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune…
Read More...

TenNor Therapeutics (Suzhou) Limited, a clinical-stage biopharmaceutical company dedicated to research and development of differentiated products for the treatment of diseases…
Read More...

Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics' proprietary VELP platform to develop…
Read More...

Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, and Lonza announced their agreement in support of ARU-1801, Aruvant's one-time…
Read More...

Today Syntegra and the National Institutes of Health (NIH) have announced a collaboration to validate Syntegra's AI-enabled synthetic data technology to advance the understanding of and…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for XALKORI (crizotinib) for the treatment of pediatric…
Read More...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union and the UK for an additional dosing option, a 1,500mg fixed dose every four weeks, in locally advanced,…
Read More...

Thermo Fisher Scientific Inc. and Groupe Novasep SAS (Novasep) announced that Thermo Fisher has completed the acquisition of Henogen S.A., Novasep's viral vector manufacturing business…
Read More...

Novartis announced that the U.S. Food and Drug Administration (FDA) has granted ligelizumab (QGE031) Breakthrough Therapy designation for the treatment of chronic spontaneous urticaria…
Read More...